Mirabegron: a decade of study [PDF]
Translational Andrology and Urology, 2020 openaire +2 more sources
Mirabegron: β3-adrenergic receptor agonist for the treatment of overactive bladder.
, 2013 OBJECTIVE: To review the place in therapy of mirabegron, a new oral β3-adrenergic receptor agonist, for the treatment of overactive bladder (OAB). DATA SOURCES: A literature search of MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations Databases
Friia, Nicholas J +3 more
core +1 more source
Mirabegron is a beta-3 adrenergic receptor agonist and is specified for the treatment of overactive Bladder. This review covers analytical methods aimed at the identification and quantification of mirabegron in bulk, commercial dosage forms, and ...
GODSE, SHITAL DIGAMBAR +1 more
core +1 more source
Comparative Neoplasm Risk of Mirabegron and Antimuscarinic Therapy in Overactive Bladder: A Multicenter Target Trial Emulation. [PDF]
Cancers (Basel)Yen FS +6 more
europepmc +1 more source
Exploratory clinical and urodynamic changes associated with mirabegron-containing multimodal treatment in children with non-monosymptomatic nocturnal enuresis: a retrospective real-world study. [PDF]
Front PediatrCai Z, Silang J, Ma X, Gesang D.
europepmc +1 more source
Prescription Trends in the Management of Lower Urinary Tract Symptoms in Men: An Online Survey of Indian Urologists. [PDF]
CureusPatwardhan P +4 more
europepmc +1 more source
Clinical efficacy of bladder hydrodistension combined with oral mirabegron and intravesical instillation in the treatment of interstitial cystitis. [PDF]
Pak J Med SciDu L, Ma Z, Xue W, Li W.
europepmc +1 more source
Sex-Dependent Cardiac Responses to β3-Adrenergic Receptor Activation in a Murine Model of Heart Failure with Preserved Ejection Fraction. [PDF]
BiomedicinesThibodeau SÈ +5 more
europepmc +1 more source